Document is current
Any future updates will be listed below
-
Authors
Mori, Hiroshi
Fujisawa, Takatomo
Higashi, Koichi
Tanizawa, Yasuhiro
Nakagawa, Zenichi
Nishide, Hiroyo
Fujiyoshi, Masaki
Nakamura, Yasukazu
Uchiyama, Ikuo
Matsui, Motomu
Yamada, Takuji
-
Funding
Funding for this research was provided by:
Japan Science and Technology Agency (JPMJND2206)
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 18 February 2026
First Online: 16 March 2026
Declarations
:
: Not applicable.
: Not applicable.
: T.Y. is a founder of Metagen Inc., Metagen Therapeutics Inc., and digzyme Inc. Metagen Inc. focuses on the design and control of the gut environment for human health. Metagen Therapeutics Inc. focuses on drug discovery and development which utilizes microbiome science. All of the companies had no control over the interpretation, writing, or publication of this work.
